Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v1-EN
Language French English
Date Updated 2023-05-06 2023-04-14
Drug Identification Number 02244726 02244726
Brand name APO-MEDROXY TABLETS APO-MEDROXY TABLETS
Common or Proper name MEDROXYPROGESTERONE MEDROXYPROGESTERONE
Company Name APOTEX INC APOTEX INC
Ingredients MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE
Strength(s) 2.5MG 2.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code G03DA G03DA
ATC description PROGESTOGENS PROGESTOGENS
Reason for shortage Shortage of an active ingredient. Shortage of an inactive ingredient or component.
Anticipated start date 2023-07-01 2023-07-01
Actual start date
Estimated end date 2023-08-31 2023-11-28
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments